Executive record
Alpha ID: alpha:person:frank-stokes-cstlVersion: public-0:d751713988987e9331980363e24189ceAs of: 2026-10-06
- Executive
Leadership, in context.
Connect capital, control, accountability, and evidence.
Explore the record
ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.Key Claims
- Professional RoleChief Financial Officer at CASTLE BIOSCIENCES INCwww.sec.gov
- Executive titleExecutive title: Chief Financial OfficerCSTL DEF 14A executive officers +1 sources
- AI and ML experienceAI and ML experience: not identified in the cited filingCSTL DEF 14A executive officers
- AI expertiseAI expertise: not identified in the cited filingCSTL executive roster source
Biography
Frank Stokes has served as Chief Financial Officer since December 2017, previously serving as CFO of Hammock Pharmaceuticals and as a Managing Director at Leerink Swann (SVB Leerink) and Robert W. Baird Co., leading life sciences investment banking efforts. He holds a B.S. in business administration and a J.D. and MBA from the University of North Carolina at Chapel Hill.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Board service
Board service coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageExecutive career
- Current · dates not publishedChief Financial Officer · CASTLE BIOSCIENCES INC
- 2026 to end not publishedExecutive title: Chief Financial Officer · Organization not publishedCSTL DEF 14A executive officers
Claims
Compensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageConflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Additional published Claims
Published evidence records
3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
CSTL DEF 14A executive officers
sec filing · Source published: Apr 8, 2026 · Retrieved: May 15, 2026
Supports 6 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
- Executive company: Executive at CASTLE BIOSCIENCES INC · Claim reviewed: May 15, 2026
- Executive title: Executive title: Chief Financial Officer · Claim reviewed: May 15, 2026
- Other Company Role: Frank Stokes is also linked to Exagen Inc. as Director. · Claim reviewed: May 15, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026
Open source
sec def 14a · Source published: Apr 8, 2026 · Retrieved: Sep 6, 2026
Supports 1 claim
- Professional Role: Chief Financial Officer at CASTLE BIOSCIENCES INC · Claim reviewed: Sep 6, 2026
CSTL executive roster source
sec filing · Source published: Date unavailable · Retrieved: May 3, 2026
Supports 5 claims
- AI expertise: AI expertise: not identified in the cited filing · Claim reviewed: May 3, 2026
- AI governance relevance: AI governance relevance: not identified in the cited filing · Claim reviewed: May 3, 2026
- Executive company: Executive at CASTLE BIOSCIENCES INC · Claim reviewed: May 15, 2026
- Executive function: Finance Controls (CFO) · Claim reviewed: May 3, 2026
- Executive title: Executive title: Chief Financial Officer · Claim reviewed: May 15, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
corroborated
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-06
- Biography
- published
- Board service
- not observed
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope